Literature DB >> 14751084

New antiangiogenic agents for renal cell carcinoma: interferon alfa and thalidomide.

Ronald M Bukowski1.   

Abstract

Entities:  

Year:  2004        PMID： 14751084     DOI： 10.1007/s11912-004-0018-1

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


× No keyword cloud information.
  8 in total

Review 1.  Renal-cell carcinoma.

Authors:  R J Motzer; N H Bander; D M Nanus
Journal:  N Engl J Med       Date:  1996-09-19       Impact factor: 91.245

Review 2.  Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma.

Authors:  J R Gnarra; D R Duan; Y Weng; J S Humphrey; D Y Chen; S Lee; A Pause; C F Dudley; F Latif; I Kuzmin; L Schmidt; F M Duh; T Stackhouse; F Chen; T Kishida; M H Wei; M I Lerman; B Zbar; R D Klausner; W M Linehan
Journal:  Biochim Biophys Acta       Date:  1996-03-18

Review 3.  Molecular and biological properties of vascular endothelial growth factor.

Authors:  N Ferrara
Journal:  J Mol Med (Berl)       Date:  1999-07       Impact factor: 4.599

4.  Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma.

Authors:  Robert J Motzer; Jennifer Bacik; Barbara A Murphy; Paul Russo; Madhu Mazumdar
Journal:  J Clin Oncol       Date:  2002-01-01       Impact factor: 44.544

5.  Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo.

Authors:  K J Kim; B Li; J Winer; M Armanini; N Gillett; H S Phillips; N Ferrara
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

6.  Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene.

Authors:  J R Gnarra; S Zhou; M J Merrill; J R Wagner; A Krumm; E Papavassiliou; E H Oldfield; R D Klausner; W M Linehan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

7.  Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.

Authors:  O Iliopoulos; A P Levy; C Jiang; W G Kaelin; M A Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

8.  Mutations of the VHL tumour suppressor gene in renal carcinoma.

Authors:  J R Gnarra; K Tory; Y Weng; L Schmidt; M H Wei; H Li; F Latif; S Liu; F Chen; F M Duh
Journal:  Nat Genet       Date:  1994-05       Impact factor: 38.330
  8 in total
  1 in total

1.  Hypertension complicating cancer chemotherapy.

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-07       Impact factor: 3.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.